PMID- 12168108 OWN - NLM STAT- MEDLINE DCOM- 20030324 LR - 20041117 IS - 1019-6439 (Print) IS - 1019-6439 (Linking) VI - 21 IP - 3 DP - 2002 Sep TI - Differentiation of monoblastic cell line UG3 into leukemic dendritic cells. PG - 617-20 AB - Dendritic cells (DCs) are known to be generated from leukemic clone from patients with acute and chronic leukemia when cultured in the presence of combination of granulocyte-macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor-alpha (TNF-alpha) and interleukin-4. However, there have been few reports that showed DCs could be effectively differentiated from human leukemia cell lines. In this study, we have shown that a human monoblastic cell line, UG3, was inducible to differentiate into DCs in the presence of GM-CSF and TNF-alpha along monocyte-macrophage lineage. These DCs, consistently displayed dendritic morphology, phenotypes and allogeneic T-cell stimulating capacity. UG3 cells thus may represent a suitable model to further elucidate characteristics of DC differentiation. FAU - Fujii, Nobuharu AU - Fujii N AD - Second Department of Internal Medicine, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. FAU - Ikeda, Takashi AU - Ikeda T FAU - Ikeda, Kazuma AU - Ikeda K FAU - Hiraki, Akio AU - Hiraki A FAU - Kawakami, Kimihiko AU - Kawakami K FAU - Masuda, Kozo AU - Masuda K FAU - Maeda, Yoshinobu AU - Maeda Y FAU - Hatake, Kiyohiko AU - Hatake K FAU - Motoyoshi, Kazuo AU - Motoyoshi K FAU - Harada, Mine AU - Harada M FAU - Tanimoto, Mitsune AU - Tanimoto M LA - eng PT - Journal Article PL - Greece TA - Int J Oncol JT - International journal of oncology JID - 9306042 RN - 0 (Tumor Necrosis Factor-alpha) RN - 83869-56-1 (Granulocyte-Macrophage Colony-Stimulating Factor) SB - IM MH - Antigen Presentation/immunology MH - Cell Differentiation/drug effects/physiology MH - Cell Line MH - Dendritic Cells/*cytology/drug effects/immunology MH - Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology MH - Humans MH - Immunophenotyping MH - Lymphocyte Activation/immunology MH - Monocytes/*cytology/drug effects/immunology MH - Tumor Necrosis Factor-alpha/pharmacology EDAT- 2002/08/09 10:00 MHDA- 2003/03/26 04:00 CRDT- 2002/08/09 10:00 PHST- 2002/08/09 10:00 [pubmed] PHST- 2003/03/26 04:00 [medline] PHST- 2002/08/09 10:00 [entrez] PST - ppublish SO - Int J Oncol. 2002 Sep;21(3):617-20.